fda compounding semaglutide update today Weight FDA Warns on Certain Forms

Similarly, Wekesa et al

A 2014 paper summarized the role of cortisone in tendinopathies this way, Overall it is clear that the local administration of glucocorticoid has significant negative effects on tendon cells in vitro, including reduced cell viability, cell proliferation and collagen synthesis.There is increased collagen disorganisation and necrosis as shown by in vivo studies.The mechanical properties of tendon are also significantly reduced.This review supports the emerging clinical evidence that shows significant long-term harms to tendon tissue and cells associated with glucocorticoid injections. Another 2014 paper gives one possible mechanism for cortisones damaging effect on tendons

Did You Know Preclinical studies in animal models showed Retatrutide produced greater reduction of fat mass relative to lean mass compared to single or dual agonist compounds

Individuals with Obesity or Type 2 Diabetes: Likely to benefit from both the metabolic and alcohol-reducing effects

Compounded semaglutide is not FDA approved and is prepared by a licensed compounding pharmacy